Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about BMRN

Recent news which mentions BMRN

< Previous 1 2 3 4 5 6 7 Next >
The Analyst Landscape: 29 Takes On Biomarin Pharmaceutical
Tickers BMRN
Tags BMRN Analyst Ratings Market News
From Benzinga
Peering Into Biomarin Pharmaceutical's Recent Short Interest
Tickers BMRN
Tags BZI/SHORTHIST Short Ideas BMRN
From Benzinga
CAMP4 Analyst Highlights Rare Disease Platform Potential
Tickers BMRN CAMP NEWS
Tags Stories That Matter Top Stories Analyst Color
From Benzinga
BioMarin's Pipeline Faces Skepticism As Analyst Questions Future Growth
Tickers ASND BMRN NEWS SHL
Tags SHL Analyst Ratings Market News
From Benzinga
In-Depth Examination Of 29 Analyst Recommendations For Biomarin Pharmaceutical
Tickers BMRN
Tags Analyst Ratings BMRN Market News
From Benzinga
A Look Ahead: Biomarin Pharmaceutical's Earnings Forecast
Tickers BMRN
Tags Benzinga BZI/EP BMRN
From Benzinga
How Is The Market Feeling About Biomarin Pharmaceutical?
Tickers BMRN
Tags Market News BMRN Short Ideas
From Benzinga
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Tickers AMGN AZN BMRN GILD
Tags GILD Market News LLY
From Benzinga
Analyst Expectations For Biomarin Pharmaceutical's Future
Tickers BMRN
Tags Analyst Ratings BMRN Market News
From Benzinga
BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish
Tickers ASND BMRN NEWS
Tags BMRN Briefs News
From Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $14,000 Today
Tickers BMRN NEWS
Tags Benzinga BZI/POD Trading Ideas
From Benzinga
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
Tickers AJG ASND BMRN BNTX
Tags BNTX FDX Trading Ideas
From Benzinga
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
Tickers AA ABNB AGRO BMRN
Tags PT Changes DOCS JBL
From Benzinga
Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term
Tickers ASND BMRN NEWS
Tags Health Care Biotech Benzinga
From Benzinga
(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
Tickers BMRN
Tags Trading Ideas Short Sellers Benzinga
From Benzinga
FDA Battles Backlog of Drug Factory Inspections Since COVID-19
Tickers BMRN BMY GSK LLY
Tags General Government News
From Benzinga
BioMarin Restructures, Outlines Roadmap To $4B Revenues By 2027
Tickers BMRN NEWS
Tags Benzinga Market News Health Care
From Benzinga
Deep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (14 Ratings)
Tickers BMRN
Tags Market News BMRN Analyst Ratings
From Benzinga
Ascendis Pharma Faces Challenges With Skytrofa And Yorvipath Pricing: Analysts Weigh In
Tickers ASND BMRN NEWS NVO
Tags Benzinga PFE NVO
From Benzinga
(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
Tickers BMRN
Tags Benzinga Trading Ideas Short Sellers
From Benzinga
Beyond The Numbers: 11 Analysts Discuss Biomarin Pharmaceutical Stock
Tickers BMRN
Tags Benzinga BZI/AAR Market News
From Benzinga
Palo Alto Networks To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday
Tickers BMRN EL FN GLOB
Tags EL Market News H
From Benzinga
$1000 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today
Tickers BMRN NEWS
Tags BZI/POD Trading Ideas Benzinga
From Benzinga
Rare Disease-Focused BioMarin Narrows Sales Focus, Cuts Cost For Hemophilia A Gene Therapy; Lifts Annual Guidance
Tickers BMRN NEWS
Tags Benzinga Trading Ideas Analyst Ratings
From Benzinga
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
Tickers APO BMRN BRBR BVS
Tags BVS MTRN KVUE
From Benzinga
Biomarin Pharmaceutical Analysts Boost Their Forecasts Following Better-Than-Expected Q2 Results
Tickers BMRN NEWS
Tags Benzinga Analyst Ratings Market News
From Benzinga
BMRN Stock Earnings: Biomarin Pharmaceutical Beats EPS, Beats Revenue for Q2 2024
Tickers BMRN
Tags Market News BMRN Earnings Reports
From InvestorPlace
A Glimpse Into The Expert Outlook On Biomarin Pharmaceutical Through 10 Analysts
Tickers BMRN
Tags Analyst Ratings BMRN Market News
From Benzinga
$100 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today
Tickers BMRN NEWS
Tags Benzinga BZI/POD Trading Ideas
From Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $16,000 Today
Tickers BMRN NEWS
Tags News Market News BMRN
From Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.